Paolo Tarantino is a Breast Medical Oncologist and Clinical Researcher. He’s currently pursuing an Advanced Research Fellowship at Dana-Farber Cancer Institute at Harvard Medical School (Boston, MA) and a PhD in clinical research at the University of Milan. His research focuses on the study of the HER2 oncoprotein, the development of novel antibody-drug conjugates (ADCs) and the identification and validation of predictive biomarkers for the use of ADCs.